- €4.57bn
- €8.85bn
- €14.90bn
- 62
- 86
- 92
- 95
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 6,913 | 7,079 | 10,555 | 20,082 | 14,897 |
Cost of Revenue | |||||
Gross Profit | 3,492 | 3,712 | 3,948 | 3,340 | 5,400 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 6,285 | 6,530 | 9,944 | 19,548 | 14,066 |
Operating Profit | 628 | 550 | 612 | 534 | 832 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 528 | 435 | 407 | 409 | 656 |
Provision for Income Taxes | |||||
Net Income After Taxes | 402 | 323 | 373 | 332 | 456 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 386 | 303 | 334 | 255 | 441 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 386 | 303 | 334 | 255 | 441 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.223 | 0.211 | 0.238 | 0.147 | 0.343 |
Dividends per Share |